Trevi Therapeutics Inc (NASDAQ:TRVI)
| 1.91 Delayed Data As of 3:59pm ET |  +0.09 / +4.95%Today’s Change | 0.46 Today|||52-Week Range 4.68 | +144.18% Year-to-Date |
Latest TRVI News | Press Releases
No recent news for Trevi Therapeutics Inc.
Today’s Trading
| Previous close | 1.82 |
| Today’s open | 1.90 |
| Day’s range | 1.88 - 1.91 |
| Volume | 429 |
| Average volume (3 months) | 252,472 |
| Market cap | $111.5M |
Data as of 3:59pm ET, 11/28/2022
Growth & Valuation
| Earnings growth (last year) | +18.08% |
| Earnings growth (this year) | +64.60% |
| Earnings growth (next 5 years) | -- |
| Revenue growth (last year) | -- |
| P/E ratio | NM |
| Price/Sales | -- |
| Price/Book | 3.11 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| DRRXDURECT Corp | -0.02 | -4.17% |
| SESNSesen Bio Inc | -0.00 | -0.83% |
| GLYCGlycoMimetics Inc | +0.09 | +4.39% |
| SLGLSol Gel Technologies... | 0.00 | 0.00% |
Data as of 3:59pm ET, 11/28/2022
Financials
| Next reporting date | March 22, 2023 |
| EPS forecast (this quarter) | -$0.09 |
| Annual revenue (last year) | $0.00 |
| Annual profit (last year) | -$33.9M |
| Net profit margin | -- |
Profile
Sector Health Technology |
Industry Pharmaceuticals: Major |
No executives to display |
Corporate headquarters New Haven, Connecticut |
Forecasts
